Saturday 17 October 2026
Export PNTG’s income statement to Excel — free account
The Pennant Group, Inc.
PNTG Healthcare Medical Care Facilities
The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024. In the quarter to June 2026, revenue grew 35.8%, EPS grew 23.8%, free cash flow fell 50.9% and total debt rose 433.8%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.
41.80
0.47
−1.11%
Follow PNTG
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
39.31 | 34.25 | 32.36 | 31.92 |
+8 more quarters Free account |
P/S ratio |
1.17 | 1.03 | 1.03 | 1.03 | |
P/FCF ratio |
37.11 | 20.85 | 26.84 | 24.17 | |
P/Operating CF |
58.96 | (310.85) | 46.42 | 62.68 | |
P/B ratio |
3.18 | 2.72 | 2.60 | 2.54 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 14.53 | |
EV/Sales |
1.33 | 1.20 | 1.19 | 1.08 | |
EV/EBITDA |
20.02 | 18.32 | 18.43 | 17.37 | |
EV/Operating CF |
27.57 | 18.50 | 23.39 | 19.05 | |
EV/FCF |
42.36 | 24.09 | 31.16 | 25.28 | |
Quick Ratio |
0.97 | 0.99 | 0.95 | 0.90 | |
Current Ratio |
1.20 | 1.19 | 1.14 | 1.04 | |
Net Debt/EBITDA |
8.85 | 8.15 | 7.81 | 1.89 | |
Debt/Assets |
19.04% | 17.74% | 17.96% | 3.45% | |
Debt/Equity |
0.49 | 0.44 | 0.46 | 0.08 | |
Asset Turnover |
1.23 | 1.20 | 1.15 | 1.21 | |
Operating CF/Net income |
2.40 | (0.40) | 2.43 | 2.29 | |
Capex/Depreciation |
(1.86) | (1.80) | (1.37) | (1.52) | |
Interest Coverage |
5.13 | 5.64 | 5.37 | 10.08 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.25% | 6.90% | 6.69% | 8.42% | |
Intangible Assets out of Total Assets |
0.42 | 0.46 | 0.45 | 0.38 | |
Share Based Compensation of Revenue |
0.99% | 0.88% | 0.75% | 1.07% | |
Graham Net Nets |
(0.35) | (0.39) | (0.44) | (0.34) | |
Graham Number |
15.67 | 14.99 | 14.56 | 13.28 | |
Earnings Yield |
2.54% | 2.92% | 3.09% | 3.13% | |
Free Cash Flow Yield |
2.69% | 4.80% | 3.73% | 4.14% | |
Revenue per Share |
8.55 | 8.22 | 8.37 | 6.62 | |
Operating CF per Share |
0.63 | (0.10) | 0.61 | 0.40 | |
Capex per Share |
(0.18) | (0.15) | (0.10) | (0.10) | |
Free Cash Flow per Share |
0.44 | (0.25) | 0.50 | 0.30 | |
Cash per Share |
0.44 | 0.14 | 0.49 | 0.07 | |
Shareholders Equity per Share |
11.61 | 11.21 | 10.83 | 9.91 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
11.61 | 11.21 | 10.83 | 9.91 | |
Free Cash Flow |
15.49 | (8.67) | 17.40 | 10.47 | |
Working Capital |
31.19 | 24.25 | 20.14 | 4.62 | |
Capital Expenditures |
(6.34) | (5.27) | (3.56) | (3.46) | |
Net Current Asset Value |
(449.26) | (414.22) | (426.52) | (296.63) | |
EV/EBIT |
23.63 | 21.64 | 21.77 | 20.91 | |
Capex to Sales |
0.02 | 0.02 | 0.01 | 0.02 | |
Price to Operating Income |
20.70 | 18.72 | 18.75 | 19.99 | |
| Other line items | |||||
Average Receivables |
114.45 | 108.91 | 102.21 | 90.05 | |
Average Payables |
22.73 | 20.80 | 21.95 | 18.76 | |
Average Assets |
894.35 | 850.05 | 823.85 | 700.20 | |
Average Common Equity |
369.03 | 356.23 | 343.11 | 265.17 |
Columns are period end dates